Prostate Cancer

A new drug combination could significantly delay the progression of a life-threatening form of prostate cancer in men with specific genetic mutations

The American Cancer Society study shows the highest mortality rates are among Black and Native American men

How are new diagnostic tools changing cancer screening?

From precision oncology to gene editing, these standout trials could redefine how we diagnose and treat rare diseases and cancer

In a statement, the American Association for Cancer Research emphasizes the critical role of sustained federal investment in advancing diagnostics, treatments, and equitable access to care for all cancer patients

First multicenter study of cell-free RNA and DNA methylation biomarkers in seminal fluid shows promise for accurate, noninvasive detection of clinically significant prostate cancer

As the frequency of late-stage cancer diagnoses rises, more accurate and efficient screening methods are needed to address overspending and improve early detection outcomes

PROSTOX ultra is the first and only molecular diagnostic test to use biology and genetics to predict radiation toxicity

The test could enable at-home testing and increased access to testing for patients undergoing telehealth care or living in remote areas

A third of Phase 2 clinical trials were terminated in 2024, a 50 percent increase from before the pandemic